Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Although certain inherited forms of CAA with cerebral haemorrhage are associated with autosomal dominant mutations in APP and other genes (cystatin-C, transthyretin, gelsolin, ABrit, ADan), in most cases of AD CAA does not associate clearly with any genetic risk factor other than APO E beta4 allele, which appears to increase the severity of CAA in a dose dependent manner, especially within the occipital cortex.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[Although certain inherited forms of CAA with cerebral haemorrhage are associated with autosomal dominant mutations in APP and other genes (cystatin-C, transthyretin, gelsolin, ABrit, ADan), in most cases of AD CAA does not associate clearly with any genetic risk factor other than APO E beta4 allele, which appears to increase the severity of CAA in a dose dependent manner, especially within the occipital cortex.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Although certain inherited forms of CAA with cerebral haemorrhage are associated with autosomal dominant mutations in APP and other genes (cystatin-C, transthyretin, gelsolin, ABrit, ADan), in most cases of AD CAA does not associate clearly with any genetic risk factor other than APO E beta4 allele, which appears to increase the severity of CAA in a dose dependent manner, especially within the occipital cortex.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP761973.RATmErVslYvzYHSQN-edSukVTrJ2T14rHlWaVgqhSnCLg130_assertion description "[Although certain inherited forms of CAA with cerebral haemorrhage are associated with autosomal dominant mutations in APP and other genes (cystatin-C, transthyretin, gelsolin, ABrit, ADan), in most cases of AD CAA does not associate clearly with any genetic risk factor other than APO E beta4 allele, which appears to increase the severity of CAA in a dose dependent manner, especially within the occipital cortex.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP761973.RATmErVslYvzYHSQN-edSukVTrJ2T14rHlWaVgqhSnCLg130_provenance.
• NP436976.RAcPDdPtYQMMUeRUhd4AVVwWdxopswSDpGfPjZj8O3VF0130_assertion description "[Although certain inherited forms of CAA with cerebral haemorrhage are associated with autosomal dominant mutations in APP and other genes (cystatin-C, transthyretin, gelsolin, ABrit, ADan), in most cases of AD CAA does not associate clearly with any genetic risk factor other than APO E beta4 allele, which appears to increase the severity of CAA in a dose dependent manner, especially within the occipital cortex.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP436976.RAcPDdPtYQMMUeRUhd4AVVwWdxopswSDpGfPjZj8O3VF0130_provenance.
• NP969318.RAdFMkhLfwAcqEfTUVQUSNS-L-Kx0rXOdTT9Vnq6r0cTI130_assertion description "[Although certain inherited forms of CAA with cerebral haemorrhage are associated with autosomal dominant mutations in APP and other genes (cystatin-C, transthyretin, gelsolin, ABrit, ADan), in most cases of AD CAA does not associate clearly with any genetic risk factor other than APO E beta4 allele, which appears to increase the severity of CAA in a dose dependent manner, especially within the occipital cortex.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP969318.RAdFMkhLfwAcqEfTUVQUSNS-L-Kx0rXOdTT9Vnq6r0cTI130_provenance.
• NP493454.RAbwxiA2FnizLdgXR88j1V1tcZVKC91evwAYropKcQsHs130_assertion description "[Although certain inherited forms of CAA with cerebral haemorrhage are associated with autosomal dominant mutations in APP and other genes (cystatin-C, transthyretin, gelsolin, ABrit, ADan), in most cases of AD CAA does not associate clearly with any genetic risk factor other than APO E beta4 allele, which appears to increase the severity of CAA in a dose dependent manner, especially within the occipital cortex.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP493454.RAbwxiA2FnizLdgXR88j1V1tcZVKC91evwAYropKcQsHs130_provenance.
• NP247114.RAhFL8U2pzx30DFjFja82Lt1OokZP494nc3bhhpJRVZP0130_assertion description "[Although certain inherited forms of CAA with cerebral haemorrhage are associated with autosomal dominant mutations in APP and other genes (cystatin-C, transthyretin, gelsolin, ABrit, ADan), in most cases of AD CAA does not associate clearly with any genetic risk factor other than APO E beta4 allele, which appears to increase the severity of CAA in a dose dependent manner, especially within the occipital cortex.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP247114.RAhFL8U2pzx30DFjFja82Lt1OokZP494nc3bhhpJRVZP0130_provenance.
• NP493451.RAkb4PuA7csvkX7cadELtAZpySF0DfVYnOC2Ca4H_HFVI130_assertion description "[Although certain inherited forms of CAA with cerebral haemorrhage are associated with autosomal dominant mutations in APP and other genes (cystatin-C, transthyretin, gelsolin, ABrit, ADan), in most cases of AD CAA does not associate clearly with any genetic risk factor other than APO E beta4 allele, which appears to increase the severity of CAA in a dose dependent manner, especially within the occipital cortex.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP493451.RAkb4PuA7csvkX7cadELtAZpySF0DfVYnOC2Ca4H_HFVI130_provenance.
• NP493453.RAlgsV7htTJIqGSoz9e3opp0eOSAjRAVxiqKtPHTI7abY130_assertion description "[Although certain inherited forms of CAA with cerebral haemorrhage are associated with autosomal dominant mutations in APP and other genes (cystatin-C, transthyretin, gelsolin, ABrit, ADan), in most cases of AD CAA does not associate clearly with any genetic risk factor other than APO E beta4 allele, which appears to increase the severity of CAA in a dose dependent manner, especially within the occipital cortex.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP493453.RAlgsV7htTJIqGSoz9e3opp0eOSAjRAVxiqKtPHTI7abY130_provenance.
• NP333599.RA10I9tWp7iOtAOn70nh8LrcPaPSknmYT-d0zQuiAVmY8130_assertion description "[Although certain inherited forms of CAA with cerebral haemorrhage are associated with autosomal dominant mutations in APP and other genes (cystatin-C, transthyretin, gelsolin, ABrit, ADan), in most cases of AD CAA does not associate clearly with any genetic risk factor other than APO E beta4 allele, which appears to increase the severity of CAA in a dose dependent manner, especially within the occipital cortex.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP333599.RA10I9tWp7iOtAOn70nh8LrcPaPSknmYT-d0zQuiAVmY8130_provenance.
• NP493448.RA7SbVlEZqFb6XmbNUwBRnUrj_5a9XjDysgnRZsvgWluk130_assertion description "[Although certain inherited forms of CAA with cerebral haemorrhage are associated with autosomal dominant mutations in APP and other genes (cystatin-C, transthyretin, gelsolin, ABrit, ADan), in most cases of AD CAA does not associate clearly with any genetic risk factor other than APO E beta4 allele, which appears to increase the severity of CAA in a dose dependent manner, especially within the occipital cortex.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP493448.RA7SbVlEZqFb6XmbNUwBRnUrj_5a9XjDysgnRZsvgWluk130_provenance.
• NP493449.RA9jZwwjsLQH8MjBdM3NECyj20BYc-69Pn172wXtU39uM130_assertion description "[Although certain inherited forms of CAA with cerebral haemorrhage are associated with autosomal dominant mutations in APP and other genes (cystatin-C, transthyretin, gelsolin, ABrit, ADan), in most cases of AD CAA does not associate clearly with any genetic risk factor other than APO E beta4 allele, which appears to increase the severity of CAA in a dose dependent manner, especially within the occipital cortex.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP493449.RA9jZwwjsLQH8MjBdM3NECyj20BYc-69Pn172wXtU39uM130_provenance.
• NP493452.RA0nyKWoSHZdT5QnE_cb43vKnaNxd2UL-6cpCdUVGW8qc130_assertion description "[Although certain inherited forms of CAA with cerebral haemorrhage are associated with autosomal dominant mutations in APP and other genes (cystatin-C, transthyretin, gelsolin, ABrit, ADan), in most cases of AD CAA does not associate clearly with any genetic risk factor other than APO E beta4 allele, which appears to increase the severity of CAA in a dose dependent manner, especially within the occipital cortex.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP493452.RA0nyKWoSHZdT5QnE_cb43vKnaNxd2UL-6cpCdUVGW8qc130_provenance.